BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9934950)

  • 1. Venlafaxine-fluoxetine interaction.
    Benazzi F
    J Clin Psychopharmacol; 1999 Feb; 19(1):96-8. PubMed ID: 9934950
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
    Benazzi F
    Can J Psychiatry; 1997 Nov; 42(9):980-1. PubMed ID: 9429070
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
    Clerc GE; Ruimy P; Verdeau-Pallès J
    Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic toxic syndrome with venlafaxine-desipramine combination.
    Benazzi F
    Pharmacopsychiatry; 1998 Jan; 31(1):36-7. PubMed ID: 9524985
    [No Abstract]   [Full Text] [Related]  

  • 5. Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study.
    Ricca V; Mannucci E; Paionni A; Di Bernardo M; Cellini M; Cabras PL; Rotella CM
    Eat Weight Disord; 1999 Mar; 4(1):10-4. PubMed ID: 10728173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High venlafaxine serum levels after prior fluoxetine medication.
    Gerbaulet M; Engel A; Hiemke C; Dahmen N
    J Clin Psychopharmacol; 2012 Apr; 32(2):295-7. PubMed ID: 22388163
    [No Abstract]   [Full Text] [Related]  

  • 7. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
    De Nayer A; Geerts S; Ruelens L; Schittecatte M; De Bleeker E; Van Eeckhoutte I; Evrard JL; Linkowski P; Fossion P; Leyman S; Mignon A
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):115-20. PubMed ID: 12135535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.
    Diaz-Martinez A; Benassinni O; Ontiveros A; Gonzalez S; Salin R; Basquedano G; Martinez RA
    Clin Ther; 1998; 20(3):467-76. PubMed ID: 9663362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
    Tzanakaki M; Guazzelli M; Nimatoudis I; Zissis NP; Smeraldi E; Rizzo F
    Int Clin Psychopharmacol; 2000 Jan; 15(1):29-34. PubMed ID: 10836283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agranulocytosis during treatment with mianserin and venlafaxine.
    Lucht MJ; Kleinschmidt R; Maier W; Rietschel M
    J Clin Psychopharmacol; 2000 Aug; 20(4):490-1. PubMed ID: 10917414
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients.
    Dierick M; Ravizza L; Realini R; Martin A
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jan; 20(1):57-71. PubMed ID: 8861177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine and ecchymosis.
    Kohn S; Labbate LA
    Can J Psychiatry; 1997 Feb; 42(1):91. PubMed ID: 9040933
    [No Abstract]   [Full Text] [Related]  

  • 13. Venlafaxine and urinary incontinence: possible association.
    Cavanaugh GL; Martin RE; Stenson MA; Robinson DD
    Ann Pharmacother; 1997 Mar; 31(3):372. PubMed ID: 9066951
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine-induced increase in urinary frequency in 3 women.
    Hansen LK
    J Clin Psychiatry; 2004 Jun; 65(6):877-8. PubMed ID: 15291668
    [No Abstract]   [Full Text] [Related]  

  • 15. Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression.
    Judge R
    J Affect Disord; 2001 Sep; 66(1):95-8. PubMed ID: 11592259
    [No Abstract]   [Full Text] [Related]  

  • 16. A case report of paranoid delusion with venlafaxine use.
    Iraqi AH
    J Am Geriatr Soc; 2003 Jul; 51(7):1045-6. PubMed ID: 12834535
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2001; 42(5):440-1. PubMed ID: 11739916
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine plus venlafaxine in treatment-resistant depression.
    Devarajan S; Dursun SM
    J Psychopharmacol; 2005 Jul; 19(4):434-5. PubMed ID: 15983004
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine: a novel antidepressant.
    Keltner NL
    J Psychosoc Nurs Ment Health Serv; 1995 Jan; 33(1):51-3. PubMed ID: 7738872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine versus fluoxetine.
    Paton C
    J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.